BioSpace News Archive

Business

Vapotherm To Report First Quarter 2023 Financial Results

Vapotherm, Inc. (NYSE: VAPO), (“Vapotherm” or the “Company”), today announced that it will release financial results for the first quarter of 2023 after the close of trading on Wednesday, May 3, 2023.

April 27, 2023
·
2 min read
Business

InfuSystem to Report First Quarter 2023 Financial Results on May 4, 2023

InfuSystem Holdings, Inc. (NYSE American: INFU) (“InfuSystem” or the “Company”) announced today it will issue first quarter 2023 financial results on Thursday, May 4, 2023, before the market opens.

April 27, 2023
·
2 min read
Business

Precision Medicine in Mental Health Company, Circular Genomics, Appoints, Dr. Paul Sargeant as Chief Executive Officer

Circular Genomics, the leading company in developing circular RNA-based precision medicine tools, data and diagnostics for neurology and psychiatry, has appointed Paul Sargeant, PhD, to serve as Chief Executive Officer.

April 27, 2023
·
3 min read
Genetown

Oxurion Issues EUR 2.0 million in Bonds for Tranche 1 (B) of the Funding Program with Atlas Special Opportunities LLC

Oxurion NV a biopharmaceutical company developing next generation standard of care ophthalmic therapies, with clinical stage assets in vascular retinal disorders, has announced the completion of Tranche 1 of funding under the Subscription Agreement with Atlas Special Opportunities LLC.

April 27, 2023
·
2 min read
BioForest

Chinook Therapeutics to Present at Upcoming May 2023 Investor Conferences

Chinook Therapeutics, Inc., a biopharmaceutical company focused on the discovery, development and commercialization of precision medicines for kidney diseases, announced that Chinook management is scheduled to participate in the following upcoming investor conferences.

April 27, 2023
·
1 min read